Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Zentralblatt Fur Veterinarmedizin. Reihe A|September 1, 1996
Inhibition of PAF-induced platelet aggregation by WEB 2086 'in-vitro', an antagonist to the receptor for platelet-activating factor, in bovineM B da Silva, F Herion, R Raskinet, et al.
Infection and Immunity|December 1, 1988
Comparison of type 2 and type 6 fimbriae of Bordetella pertussis by using agglutinating monoclonal antibodiesZ M Li, M J Brennan, J L David, et al.
The Annals of Thoracic Surgery|January 13, 2001
SMA circuits reduce platelet consumption and platelet factor release during cardiac surgeryJ O Defraigne, J Pincemail, G Dekoster, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|July 7, 2000
Effects of a novel non-carboxylic thromboxane A2 receptor antagonist (BM-531) derived from torasemide on platelet functionJ M Dogné, X de Leval, P Neven, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|January 23, 2003
Pharmacological evaluation of the novel thromboxane modulator BM-567 (II/II). Effects of BM-567 on osteogenic sarcoma-cell-induced platelet aggregationX de Leval, V Benoit, J Delarge, et al.
European Journal of Clinical Investigation|March 16, 2002
Increased TGFbeta1 plasma level in patients with lung cancer: potential mechanismsN Barthelemy-Brichant, J L David, L Bosquée, et al.
Veterinary Research Communications|November 5, 1997
The effect of intravenous administration of WEB 2086 on PAF-induced platelet aggregation in healthy Friesian calvesM B Bastos da Silva, P Gustin, F Herion, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|January 23, 2003
Pharmacological evaluation of the novel thromboxane modulator BM-567 (I/II). Effects of BM-567 on platelet functionJ M Dogné, X de Leval, P Kolh, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|June 22, 2001
Evaluation of classical NSAIDs and COX-2 selective inhibitors on purified ovine enzymes and human whole bloodX de Leval, J Delarge, P Devel, et al.
Cardiovascular Drug Reviews|August 3, 2001
Pharmacology of the thromboxane receptor antagonist and thromboxane synthase inhibitor BM-531J M Dogné, S Rolin, X de Leval, et al.
Pageof 5